Dynavax Technologies Corp [DVAX] stock is trading at $12.49, down -1.26%. An important factor to consider is whether the stock is rising or falling in short-term value. The DVAX shares have lost -3.70% over the last week, with a monthly amount drifted -13.26%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Dynavax Technologies Corp [NASDAQ: DVAX] stock has seen the most recent analyst activity on February 11, 2025, when Goldman downgraded its rating to a Sell and also revised its price target to $12 from $15. Previously, Goldman started tracking the stock with Neutral rating on February 01, 2024, and set its price target to $20. On September 27, 2022, JMP Securities initiated with a Mkt Outperform rating and assigned a price target of $22 on the stock. Goldman initiated its recommendation with a Buy and recommended $19 as its price target on August 06, 2021. H.C. Wainwright reiterated a Buy rating for this stock on August 07, 2020, and downed its price target to $12. In a note dated August 03, 2020, H.C. Wainwright reiterated an Buy rating on this stock and boosted its target price from $12 to $14.
Dynavax Technologies Corp [DVAX] stock has fluctuated between $9.74 and $14.63 over the past year. Currently, Wall Street analysts expect the stock to reach $24.5 within the next 12 months. Dynavax Technologies Corp [NASDAQ: DVAX] shares were valued at $12.49 at the most recent close of the market. An investor can expect a potential return of 96.16% based on the average DVAX price forecast.
Analyzing the DVAX fundamentals
Dynavax Technologies Corp [NASDAQ:DVAX] reported sales of 277.25M for the trailing twelve months, which represents a growth of 29.56%. Gross Profit Margin for this corporation currently stands at 0.82% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at 0.11%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.04 and Total Capital is -0.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.43.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.08 points at the first support level, and at 11.67 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.91, and for the 2nd resistance point, it is at 13.33.
Ratios To Look Out For
For context, Dynavax Technologies Corp’s Current Ratio is 10.80. On the other hand, the Quick Ratio is 9.91, and the Cash Ratio is 1.22. Considering the valuation of this stock, the price to sales ratio is 5.60, the price to book ratio is 2.63 and price to earnings (TTM) ratio is 71.49.
Transactions by insiders
Recent insider trading involved Novack David F, President & COO, that happened on Mar 24 ’25 when 10000.0 shares were sold. Officer, DAVID NOVACK completed a deal on Mar 24 ’25 to buy 10000.0 shares. Meanwhile, President & COO Novack David F sold 14020.0 shares on Mar 18 ’25.
